Nova Minerals Limited

NVA

Nova Minerals Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Melbourne, Victoria. The firm is focused on advancing the Estelle Project, comprised of 514 square kilometers (km2) of State of Alaska mining claims, which contains multiple mining complexes across a 35 kilometers long mineralized corridor of over 20 advanced gold and antimony prospects, including two multi-million-ounce resources, and several drill ready antimony prospects. The Estelle Project is located 150 kilometers northwest of Anchorage, Alaska, the United States of America, in the prolific Tintina Gold Belt, a province which hosts a 220 million ounce (Moz) documented gold endowment and some of gold mines and discoveries including, Barrick's Donlin Creek Gold Project and Kinross Gold Corporation's Fort Knox Gold Mine. The RPM project is located in the south of the tenement and comprises: The RPM North Deposit and The RPM South Deposit.

Neurizon Therapeutics Limited

NUZ

Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-10-05. The firm is engaged in advancing treatments for neurodegenerative diseases. The firm is focused on developing its lead drug candidate, NUZ-001, for the treatment of Amyotrophic Lateral Sclerosis (ALS), which is the common form of motor neuron disease. ALS is a devastating neurodegenerative condition that primarily affects nerve cells that control voluntary muscles.